PL408981A1 - Pochodne 2,3'-anhydro-2'-deoksy-5-fluorourydyny o działaniu cytotoksycznym, sposób wytwarzania i zastosowanie - Google Patents

Pochodne 2,3'-anhydro-2'-deoksy-5-fluorourydyny o działaniu cytotoksycznym, sposób wytwarzania i zastosowanie

Info

Publication number
PL408981A1
PL408981A1 PL408981A PL40898114A PL408981A1 PL 408981 A1 PL408981 A1 PL 408981A1 PL 408981 A PL408981 A PL 408981A PL 40898114 A PL40898114 A PL 40898114A PL 408981 A1 PL408981 A1 PL 408981A1
Authority
PL
Poland
Prior art keywords
anhydro
deoxy
derivatives
fluorouridine
producing
Prior art date
Application number
PL408981A
Other languages
English (en)
Other versions
PL225283B1 (pl
Inventor
Lech Celewicz
Karol Kacprzak
Marta Lewandowska
Piotr Ruszkowski
Original Assignee
Uniwersytet Im. Adama Mickiewicza W Poznaniu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Im. Adama Mickiewicza W Poznaniu filed Critical Uniwersytet Im. Adama Mickiewicza W Poznaniu
Priority to PL408981A priority Critical patent/PL225283B1/pl
Priority to US14/420,487 priority patent/US9260468B1/en
Priority to PL14772458T priority patent/PL3172216T3/pl
Priority to CA2887025A priority patent/CA2887025C/en
Priority to PCT/PL2014/050050 priority patent/WO2015050468A1/en
Priority to CN201480002600.XA priority patent/CN105722845A/zh
Priority to JP2015544030A priority patent/JP5894351B2/ja
Priority to EP14772458.7A priority patent/EP3172216B1/en
Publication of PL408981A1 publication Critical patent/PL408981A1/pl
Publication of PL225283B1 publication Critical patent/PL225283B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C07F9/24—Esteramides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Przedmiotem wynalazku są nowe pochodne 2,3'-anhydro-2'-deoksy-5-fluorourydyny, o ogólnym wzorze 1 gdzie R oznacza grupę trifluorometylową, 2,2,2-trifluoroetylową difluorometylową, perfluoroetylową, 1-fluoroetylową, 2-fluoroetylową, 1,1-difluoroetylową, 1,2-difluoroetylową, 2,2-difluoroetylową, 1,1,2-trifluoroetylową, 1,2,2-trifluoroetylową, 1,1,2,2-tetrafluoroetylową, 1,2,2,2-tetrafluoroetylową. W drugim aspekcie przedmiotem wynalazku jest sposób wytwarzania pochodnych 2,3'-anhydro-2'-deoksy-5-fluorourydyny o ogólnym wzorze 1. W trzecim aspekcie przedmiotem wynalazku jest zastosowanie pochodnych 2,3'-anhydro-2'-deoksy-5-fluorourydyny o ogólnym wzorze 1, w terapii przeciwnowotworowej raka piersi, raka szyjki macicy, raka płuca oraz raka nosogardzieli.
PL408981A 2014-07-24 2014-07-24 Pochodne 2,3’-anhydro-2’-deoksy-5-fluorourydyny o działaniu cytotoksycznym, sposób wytwarzania i zastosowanie PL225283B1 (pl)

Priority Applications (8)

Application Number Priority Date Filing Date Title
PL408981A PL225283B1 (pl) 2014-07-24 2014-07-24 Pochodne 2,3’-anhydro-2’-deoksy-5-fluorourydyny o działaniu cytotoksycznym, sposób wytwarzania i zastosowanie
US14/420,487 US9260468B1 (en) 2014-07-24 2014-08-22 2,3′-anhydro-2′-deoxy-5-fluorouridine derivatives with cytotoxic activity, a manufacturing process and application
PL14772458T PL3172216T3 (pl) 2014-07-24 2014-08-22 Pochodne 2,3’-anhydro-2’-deoksy-5-fluorourydyny o działaniu cytotoksycznym, sposób wytwarzania i zastosowanie
CA2887025A CA2887025C (en) 2014-07-24 2014-08-22 2,3'-anhydro-2'-deoxy-5-fluorouridine derivatives with cytotoxic activity, a manufacturing process and application
PCT/PL2014/050050 WO2015050468A1 (en) 2014-07-24 2014-08-22 2,3'-Anhydro-2'-deoxy-5-fluorouridine derivatives with cytotoxic activity, a manufacturing process and application
CN201480002600.XA CN105722845A (zh) 2014-07-24 2014-08-22 2,3′-脱水-2′-脱氧-5-氟尿苷衍生物与细胞毒活性、制备方法及应用
JP2015544030A JP5894351B2 (ja) 2014-07-24 2014-08-22 細胞毒性活性を有する２，３’−アンヒドロ−２’−デオキシ−５−フルオロウリジン誘導体、その製造プロセスおよび使用
EP14772458.7A EP3172216B1 (en) 2014-07-24 2014-08-22 2,3'-anhydro-2'-déoxy-5-fluorouridine derivatives with cytotoxic activity, a manufacturing process and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL408981A PL225283B1 (pl) 2014-07-24 2014-07-24 Pochodne 2,3’-anhydro-2’-deoksy-5-fluorourydyny o działaniu cytotoksycznym, sposób wytwarzania i zastosowanie

Publications (2)

Publication Number Publication Date
PL408981A1 true PL408981A1 (pl) 2015-06-22
PL225283B1 PL225283B1 (pl) 2017-03-31

Family

ID=52778964

Family Applications (2)

Application Number Title Priority Date Filing Date
PL408981A PL225283B1 (pl) 2014-07-24 2014-07-24 Pochodne 2,3’-anhydro-2’-deoksy-5-fluorourydyny o działaniu cytotoksycznym, sposób wytwarzania i zastosowanie
PL14772458T PL3172216T3 (pl) 2014-07-24 2014-08-22 Pochodne 2,3’-anhydro-2’-deoksy-5-fluorourydyny o działaniu cytotoksycznym, sposób wytwarzania i zastosowanie

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL14772458T PL3172216T3 (pl) 2014-07-24 2014-08-22 Pochodne 2,3’-anhydro-2’-deoksy-5-fluorourydyny o działaniu cytotoksycznym, sposób wytwarzania i zastosowanie

Country Status (7)

Country Link
US (1) US9260468B1 (pl)
EP (1) EP3172216B1 (pl)
JP (1) JP5894351B2 (pl)
CN (1) CN105722845A (pl)
CA (1) CA2887025C (pl)
PL (2) PL225283B1 (pl)
WO (1) WO2015050468A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114644651A (zh) * 2022-04-13 2022-06-21 中国人民解放军军事科学院军事医学研究院 芳氧基磷酰化氨基酸酯化合物的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102464688A (zh) * 2010-11-19 2012-05-23 医影生物医药科技(上海)有限公司 胸苷环磷酸酯化合物及其抗肿瘤用途
CN103403014B (zh) * 2011-01-03 2016-07-06 河南美泰宝生物制药有限公司 O-(经取代的苯甲基)氨基磷酸酯化合物及其治疗用途
US8933053B2 (en) * 2011-03-01 2015-01-13 Nucana Biomed Limited Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer

Also Published As

Publication number Publication date
WO2015050468A1 (en) 2015-04-09
JP2015537040A (ja) 2015-12-24
CN105722845A (zh) 2016-06-29
CA2887025A1 (en) 2015-04-09
US9260468B1 (en) 2016-02-16
EP3172216B1 (en) 2018-10-10
EP3172216A1 (en) 2017-05-31
PL225283B1 (pl) 2017-03-31
JP5894351B2 (ja) 2016-03-30
CA2887025C (en) 2016-01-05
PL3172216T3 (pl) 2019-04-30
US20160024133A1 (en) 2016-01-28

Similar Documents

Publication Publication Date Title
EA201600204A1 (ru) Производные хиназолина, фармацевтическая композиция на их основе и их применение для профилактики или лечения опухоли
PH12015501965A1 (en) Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
MX360634B (es) Inhibidores de 3-haloalilamina sustituidos de ssao y uso de los mismos.
SG10201808102WA (en) Bicyclic heterocycle compounds and their uses in therapy
TW201613593A (en) Molecules for administration to ROS1 mutant cancer cells
MX2015012432A (es) Inhibidores piridinicos de la cinasa cdk9.
MX2015017201A (es) Derivados de pirazolopiridina para uso en el tratamiento del cancer de vejiga.
WO2015148415A3 (en) Use of the fl118 core chemical structure platform to generate fl118 derivatives for treatment of human disease
DOP2014000255A (es) Uracilos sustituidos bicíclicamente y uso de los mismos
BR112015029386A8 (pt) uso de eribulina e lenvatinibe como terapia de combinação, composição farmacêutica compreendendo os mesmos e kit
PH12016502353A1 (en) Pharmaceutical composition
MY179605A (en) Use of benzimidazole-proline derivatives
PH12016502352A1 (en) Pharmaceutical composition
MX2018008644A (es) Derivados de 3-((hetero)aril)-alquil-8-amino-2-oxo-1,3-diaza-espir o-[4.5]-decano.
CY1117579T1 (el) Παραγωγα φαινυλιου-γουανiδiνης
EA201391438A1 (ru) Производные сулиндака, применение и получение указанных производных
UY35610A (es) Derivados de prodroga de triazolpiridinas sustituidas
PL408981A1 (pl) Pochodne 2,3'-anhydro-2'-deoksy-5-fluorourydyny o działaniu cytotoksycznym, sposób wytwarzania i zastosowanie
MX2020006075A (es) Composiciones farmaceuticas de bendamustina.
BR112017003651A2 (pt) derivados de isoquinolinona úteis no tratamento de câncer
EA201400786A1 (ru) Карбоциклические нуклеозиды, их фармацевтическое применение и композиции
PL407152A1 (pl) Pochodne 2',3'-dideoksy-5-fluorourydyny, sposób ich wytwarzania i zastosowanie
PL407153A1 (pl) Pochodne 2',5'-dideoksy-5-fluorourydyny o działaniu cytotoksycznym, sposób ich wytwarzania i zastosowanie
PL420046A1 (pl) Grupa pochodnych peptydów przeciwnowotworowych, sposób otrzymywania oraz ich zastosowanie
PL401994A1 (pl) Zastosowanie medyczne pochodnych 1-podstawionego 4-benzoilotiosemikarbazydu